Iron Chelation Therapy
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
... of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes” published in January ...
6
Is Iron Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive?
... increased iron absoption associated with ineffective ...hereditary iron-loading anemias indicate long- term consequences of iron toxicity are preventable and potentially reversible by effective ...
5
Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
... transfusional iron overload usually require iron chelation therapy (ICT) to help decrease the iron burden and to prevent and/or delay long-term complications associated with iron ...
13
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
... Citation: Marlijn Hoeks, Ge Yu, Saskia Langemeijer, Simon Crouch, Louise de Swart, Pierre Fenaux, Argiris Symeonidis, Jaroslav ermák, Eva Hellström-Lindberg, Guillermo Sanz, Reinhard Stauder, Mette Skov Holm, Moshe ...
36
Beliefs of Jordanian Children with Thalassemia toward Using Iron Chelation Therapy
... According to Horne and Weinman [10], Medication beliefs were found to be more powerful predictors of adherence to treatment than the clinical and sociodemographic variables. In addition, patients’ knowledge about their ...
11
Oral iron chelation therapy with deferiprone (L1)
... gross iron overload, several years o f regular iron chelation are required in order to reduce the body iron burden to a safe ...the iron chelator in the serum is sufficient to ...
208
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
... Poor compliance due to lack of palatability, tolerability, or QoL negatively impacted by side effects has long- term health implications given that inadequate treatment of chronic iron overload can lead to severe ...
13
Psychosocial factors influencing adherence to iron chelation therapy in patients with thalassaemia
... It is difficult to draw any conclusions about the incidence of non-adherence to desferal as a result of the many different definitions of non-adherence. The results do however indicate that only one quarter of the ...
165
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
... genotype is responsible for approximately 50% of all severe β -thalassemias worldwide (Table 1). The disorder is characterized by marked clinical variability and Hb production, ranging from a mild and asymptomatic anemia ...
17
Reversal of end stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report
... with iron overload were identified in our patient, nor were there any other novel or rare single nucleotide polymorphisms in the coding re- gions of sequenced ...
6
Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area
... guidelines, iron chelation therapy with deferoxamine is not recommended during pregnancy because its safety has not been well established ...increased iron deposition in the heart and liver, ...
12
Iron overload in beta thalassemia major patients
... of iron. Patients may accumulate 5 g of iron per year following transfusion of 25 units of blood per ...gastrointestinal iron absorption due to increased hepcidin in thalassemia patients, cause ...
8
Deferasirox in Chelation Naive Children with Transfusional Iron Overload in Basra, Iraq: A Two-Year Single Center Study
... received iron chelation therapy using DFX for at least two years and the results showed that Serum ferritin showed a steadily decreasing trend among patients over the study period in both TDT and SCD ...
8
Treating thalassemia major-related iron overload: the role of deferiprone
... three iron chelators, new imaging techniques that allow specific organ assessment of the degree of iron overload, and improvement in the treatment of ...for iron chelation in the ...body ...
11
Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review
... body iron burden in thalassemia major, and therefore preferred for research ...in iron chelation ...body iron than liver biopsy or SQUID because iron pools in the heart and liver may be ...
9
The impact of iron overload and its treatment on quality of life: results from a literature review
... Figure 1 provides an overview of the hypotheses for the impact of infusion ICT on the QoL of patients with iron overload. In thalassemia, the impact of infusion ICT on QoL is most profound, since patients are ...
6
← Return to Article Details Chelation Therapy for Cardiovascular Disease: Bringing it Back to the Future
... criteria. Chelation therapy, for a long time overshadowed by other treat- ment modalities for CAD, has recently emerged as an option recognized in the ...of chelation therapy, Trial to Assess ...
7
Chelation therapy and chelating agents of Ayurveda
... be chelation therapy, which is a technique which involves the administration of chelation agents to remove metals from the ...body. Chelation therapy is the use of chelating agents to ...
8
Chelation Therapy in Children With Subclinical Plumbism
... urinary coproporphyrin excretion and its relation to edathamil calcium disodium administration in children with acute lead intoxication. : Treatment of lead poisoning: A compari- son bet[r] ...
5
MRI evaluation of hepatic and cardiac iron burden in pediatric thalassemia major patients: spectrum of findings by T2*
... Cardiac MR-T2* values were quantified with the re- gion of interest in the ventricular septum to avoid susceptibility artifact. The region of interest was copied automatically to identical positions on images from ...
9